Davis Polk is advising Shire plc on its $750 million cash acquisition of Advanced BioHealing, Inc. The transaction is subject to customary closing conditions, including antitrust clearances.

Westport, Connecticut-based Advanced BioHealing is a privately held leading regenerative medicine company that develops, manufactures and commercializes living cell-based therapies for regenerative medicine. Dublin-based Shire is a leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.

The Davis Polk corporate team includes partner John K. Knight and associates Alexander N. Macleod, Aman Solomon, Jacqueline M. Pace (not yet admitted) and foreign temporary associate Par Johansson (not yet admitted). Partner Kyoko Takahashi Lin and associates Andrew Blau and Trevor L. Gleason (not yet admitted) are providing benefits advice. Partner Frank J. Azzopardi and associates David R. Bauer, Randy Samson and Daniel J. Ray are providing intellectual property advice. Partner Michael Mollerus and associate Kerry S. Price are providing tax advice. Counsel James P. McIntyre and associate Aaron M. Sacks are providing real estate advice. Counsel Betty Moy Huber and associate Adam Riedel are providing environmental advice. Counsel Stephen M. Pepper is providing antitrust advice. All members of the Davis Polk team are based in the New York office.